Valeant Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference

January 04, 2017

LAVAL, Quebec, Jan. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that Joseph C. Papa, Chairman and CEO, will present at the 35th Annual J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco on Tuesday, January 10, 2017 at 5:00 p.m. PST (8:00 p.m. EST).

A live webcast and audio archive of the event will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com.

Contact Information:

Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)

Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300385784.html

SOURCE Valeant Pharmaceuticals International, Inc.